Cargando…

Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis

BACKGROUND AND AIMS: In vitro studies using immortalised cancer cell lines showed that butyrate has an overall positive effect on epithelial barrier integrity, but the physiological relevance of cancer cell lines is limited. We developed epithelial monolayers from human tissue samples of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vancamelbeke, Maaike, Laeremans, Thessa, Vanhove, Wiebe, Arnauts, Kaline, Ramalho, Anabela Santo, Farré, Ricard, Cleynen, Isabelle, Ferrante, Marc, Vermeire, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764103/ https://www.ncbi.nlm.nih.gov/pubmed/30919886 http://dx.doi.org/10.1093/ecco-jcc/jjz064

Ejemplares similares

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis
por: Lee, Ho-Su, et al.
Publicado: (2020)

High Acetate Concentration Protects Intestinal Barrier and Exerts Anti-Inflammatory Effects in Organoid-Derived Epithelial Monolayer Cultures from Patients with Ulcerative Colitis
por: Deleu, Sara, et al.
Publicado: (2023)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon
por: Verstockt, Bram, et al.
Publicado: (2020)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis
por: Van der Goten, Jan, et al.
Publicado: (2014)

Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases
por: Verstockt, Bram, et al.
Publicado: (2020)

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
por: Poletti, Martina, et al.
Publicado: (2020)

Microbiota, not host origin drives ex vivo intestinal epithelial responses
por: Arnauts, Kaline, et al.
Publicado: (2022)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis
por: Faelens, Ruben, et al.
Publicado: (2021)

Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis
por: Caetano, Marcos A. F., et al.
Publicado: (2023)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice
por: Jourova, Lenka, et al.
Publicado: (2022)

Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative Colitis
por: Pereira, Márcia S., et al.
Publicado: (2020)

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program
por: Sandborn, William J., et al.
Publicado: (2020)

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
por: Winthrop, Kevin L, et al.
Publicado: (2018)

Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2021)

Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients
por: Zhou, Zheng, et al.
Publicado: (2021)

Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid
por: Li, Wei, et al.
Publicado: (2022)

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis
por: Jansen, Daan, et al.
Publicado: (2023)

Efficacy of JAK inhibitors in Ulcerative Colitis
por: Ferrante, Marc, et al.
Publicado: (2020)

Increased Proportion of Colorectal Cancer in Patients With Ulcerative Colitis Undergoing Surgery in the Netherlands
por: Heuthorst, Lianne, et al.
Publicado: (2023)

Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation
por: Xu, Hao-Ming, et al.
Publicado: (2021)

Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients
por: Osawa, Motoyasu, et al.
Publicado: (2023)

Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn’s disease
por: Sæterstad, Siri, et al.
Publicado: (2022)

The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2019)

Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome
por: Satka, Stefan, et al.
Publicado: (2022)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis
por: Ikeda, Yuka, et al.
Publicado: (2023)

Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
por: Winthrop, Kevin L, et al.
Publicado: (2022)

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
por: Creyns, Brecht, et al.
Publicado: (2020)

Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program
por: Lichtenstein, Gary R, et al.
Publicado: (2022)

Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
por: Biedermann, Luc, et al.
Publicado: (2022)

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study
por: Vernero, Marta, et al.
Publicado: (2020)

Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
por: Nyman, Margareta, et al.
Publicado: (2020)

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial
por: Vermeire, Séverine, et al.
Publicado: (2020)

Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn’s Disease or Ulcerative Colitis
por: Vermeire, Séverine, et al.
Publicado: (2020)

Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
por: Cleynen, Isabelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fgmd1vdutu8kaj18qn8vee3oi2